+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Testing Service Market - Global Forecast 2026-2032- Product Image
Molecular Testing Service Market - Global Forecast 2026-2032- Product Image
Sale

Molecular Testing Service Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283437
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Molecular Testing Services: Executive Overview

Molecular testing services analyze nucleic acids and other molecular markers to support diagnosis, screening, treatment selection, disease surveillance, and research. Their relevance is expanding as healthcare systems prioritize earlier detection, precision medicine, decentralized testing, and evidence-based clinical decision-making. Service models include laboratory testing, specimen logistics, data interpretation, and technology-enabled reporting across infectious disease, oncology, inherited conditions, reproductive health, and pharmacogenomics.

Shifts Reshaping Molecular Testing Delivery

The landscape is shifting from centralized, episodic testing toward integrated diagnostic pathways that connect collection, laboratory processing, clinical interpretation, and longitudinal data. Multiplex assays, next-generation sequencing, liquid biopsy, companion diagnostics, and point-of-care workflows are broadening the range of questions that molecular testing can address. At the same time, laboratories face stricter expectations for analytical validation, turnaround time, interoperability, quality management, reimbursement alignment, and protection of genomic information.

Artificial Intelligence Across the Testing Workflow

Artificial intelligence is influencing molecular testing through automated sample triage, quality-control monitoring, variant interpretation, image and signal analysis, workflow optimization, and clinical decision support. Its practical value depends on representative training data, transparent validation, human oversight, and integration with laboratory information systems and electronic health records. Leaders should treat AI as an augmentative capability: models can prioritize and interpret information, but laboratory professionals remain accountable for analytical validity, clinical context, and appropriate communication of results.

Regional Insights Across Global Testing Ecosystems

North America combines advanced laboratory infrastructure, strong research capacity, and active adoption of precision diagnostics, while navigating regulatory, reimbursement, and data-governance requirements. Europe emphasizes quality systems, cross-border health-data governance, and coordinated public-health capabilities, with implementation shaped by national healthcare structures. Asia-Pacific presents diverse conditions, ranging from highly sophisticated laboratory networks to access gaps that make decentralization and scalable logistics important. Latin America is prioritizing infectious-disease surveillance, oncology access, and laboratory strengthening amid uneven infrastructure. The Middle East is investing in specialized healthcare, genomics, and centralized reference capabilities, while Africa’s priorities include infectious-disease detection, resilient sample networks, workforce development, and affordable access.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members face varied laboratory maturity and benefit from interoperable referral networks, harmonized quality practices, and regional approaches to infectious-disease surveillance. BRICS economies span substantial differences in health-system capacity, making domestic manufacturing, workforce development, and affordable access important themes. The European Union is shaped by coordinated regulation, cross-border data considerations, and integration of molecular diagnostics into national systems. G7 countries generally emphasize innovation, clinical evidence, cybersecurity, and resilient supply chains. GCC states are advancing specialized healthcare and genomics while building regional capabilities, and NATO members have a shared interest in biosurveillance, preparedness, secure logistics, and continuity of diagnostic services.

Country-Level Developments and Operating Contexts

Australia is strengthening genomics, public-health surveillance, and regional access across a geographically dispersed system. Brazil is balancing sophisticated urban laboratories with broader access and infectious-disease priorities. Canada is emphasizing public laboratory capacity, equitable access, and coordinated genomic surveillance. China is expanding molecular diagnostics, sequencing capabilities, and healthcare digitization. France and Germany are integrating advanced diagnostics within regulated, quality-focused health systems, while Italy and Spain are addressing regional variation through public-sector coordination. India is scaling molecular testing, digital health, and affordable decentralized services. Japan and South Korea combine advanced technology adoption with strong quality expectations and aging-population needs. Mexico is strengthening laboratory networks and access across diverse regions. Russia’s environment reflects domestic capacity-building and public-health surveillance priorities. The United Kingdom is advancing genomics, centralized expertise, and evidence-based adoption. The United States remains focused on innovation, laboratory oversight, precision medicine, and complex reimbursement and data-governance requirements.

Actions for Leaders Building Resilient Molecular Testing Services

Industry leaders should first map testing pathways end to end, identifying bottlenecks in specimen collection, transport, processing, interpretation, reporting, and follow-up. They should prioritize assays with clear clinical utility, validate performance in the populations served, and maintain documented quality systems. Interoperability, cybersecurity, consent, privacy, and result stewardship should be designed into platforms rather than added later. Workforce investment is essential, particularly in bioinformatics, molecular pathology, quality assurance, and field logistics. AI deployments should use governed data, prospective validation, monitoring for drift and bias, and clear escalation to qualified professionals. Partnerships with health systems, public laboratories, regulators, and academic institutions can improve access while supporting surveillance and responsible innovation.

Research Methodology for the Executive Summary

This executive summary uses the defined molecular testing service scope and synthesizes established, publicly verifiable industry characteristics across clinical diagnostics, laboratory services, genomics, infectious-disease surveillance, oncology, reproductive health, and research applications. The analysis is organized by technology adoption, service delivery, regulation, infrastructure, data governance, workforce, and healthcare-system context. Regional, group, and country comparisons are qualitative and focus on documented structural conditions rather than market estimates, rankings, shares, or forecasts. Interpretation emphasizes cross-cutting drivers and implementation requirements, with claims framed conservatively where conditions vary across jurisdictions.

Conclusion: Scaling Molecular Testing with Trust and Clinical Utility

Molecular testing services are becoming a core layer of modern healthcare and public-health infrastructure. Sustainable progress will depend less on laboratory capability alone than on the reliability of complete pathways linking samples, validated methods, interpretable results, clinical action, and equitable access. Organizations that combine rigorous quality management with interoperable technology, responsible AI, resilient logistics, skilled personnel, and strong data governance will be better positioned to translate molecular information into measurable health-system value.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Molecular Testing Service Market, by Test Type
7.1. Introduction
7.2. PCR / Real-Time PCR Testing
7.3. Next-Generation Sequencing (NGS)
7.4. DNA / RNA Analysis
7.5. Gene Expression Profiling
7.6. Epigenetic / Methylation Testing
8. Molecular Testing Service Market, by Service Model
8.1. Introduction
8.2. Contract / Outsourced Testing
8.3. In-House Laboratory Services
8.4. Mobile / On-Site Testing Services
8.5. Direct-to-Consumer Testing
9. Molecular Testing Service Market, by Sample Type
9.1. Introduction
9.2. Blood / Plasma / Serum
9.3. Saliva / Buccal Swabs
9.4. Tissue Biopsies
9.5. Environmental Samples
10. Molecular Testing Service Market, by Turnaround Time
10.1. Introduction
10.2. Rapid / Same-Day Testing
10.3. Short-Term (1-3 Days)
10.4. Standard (4-7 Days)
11. Molecular Testing Service Market, by Application
11.1. Introduction
11.2. Infectious Disease Detection
11.3. Genetic / Hereditary Disease Screening
11.4. Oncology & Cancer Diagnostics
11.5. Pharmacogenomics & Personalized Medicine
11.6. Prenatal & Neonatal Screening
11.7. Food & Environmental Safety Testing
12. Molecular Testing Service Market, by End-User Industry
12.1. Introduction
12.2. Clinical Laboratories & Hospitals
12.3. Pharmaceutical & Biotechnology Companies
12.4. Research Institutions & Universities
12.5. Agricultural & Food Safety Companies
12.6. Environmental Testing & Regulatory Bodies
13. Molecular Testing Service Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Molecular Testing Service Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Molecular Testing Service Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Agilent Technologies Inc
17.3. Becton, Dickinson and Company
17.4. BGI Genomics Co Ltd
17.5. bioMérieux SA
17.6. Bio-Rad Laboratories Inc
17.7. Danaher Corporation
17.8. DiaSorin S.p.A.
17.9. Eurofins Scientific SE
17.10. Exact Sciences Corporation
17.11. F. Hoffmann-La Roche Ltd
17.12. Genetic Signatures Pty Ltd
17.13. Grifols S.A.
17.14. Hologic Inc
17.15. Illumina Inc
17.16. MDxHealth SA
17.17. Molbio Diagnostics Pvt Ltd
17.18. Myriad Genetics Inc
17.19. QIAGEN N.V.
17.20. Quest Diagnostics Incorporated
17.21. QuidelOrtho Corporation
17.22. Savyon Diagnostics Ltd
17.23. Seegene Inc
17.24. Siemens Healthineers AG
17.25. Thermo Fisher Scientific Inc
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Molecular Testing Service Market, Years Considered for the Study
FIGURE 2. Global Molecular Testing Service Market, Research Design
FIGURE 3. Global Molecular Testing Service Market, Research Framework
FIGURE 4. Global Molecular Testing Service Market, Data Triangulation
FIGURE 5. Global Molecular Testing Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Molecular Testing Service Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Molecular Testing Service Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Molecular Testing Service Market Size, by Service Model, 2025 vs 2032 (%)
FIGURE 9. Global Molecular Testing Service Market Size, by Service Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Molecular Testing Service Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Molecular Testing Service Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Molecular Testing Service Market Size, by Turnaround Time, 2025 vs 2032 (%)
FIGURE 13. Global Molecular Testing Service Market Size, by Turnaround Time, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Molecular Testing Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Molecular Testing Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Molecular Testing Service Market Size, by End-User Industry, 2025 vs 2032 (%)
FIGURE 17. Global Molecular Testing Service Market Size, by End-User Industry, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Molecular Testing Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Molecular Testing Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Molecular Testing Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Molecular Testing Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Molecular Testing Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Molecular Testing Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Molecular Testing Service Market Segmentation & Coverage
TABLE 2. Global Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global PCR / Real-Time PCR Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global PCR / Real-Time PCR Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global PCR / Real-Time PCR Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Next-Generation Sequencing (NGS) Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Next-Generation Sequencing (NGS) Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Next-Generation Sequencing (NGS) Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global DNA / RNA Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global DNA / RNA Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global DNA / RNA Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Gene Expression Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Gene Expression Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Gene Expression Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Epigenetic / Methylation Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Epigenetic / Methylation Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Epigenetic / Methylation Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 20. Global Contract / Outsourced Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Contract / Outsourced Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Contract / Outsourced Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global In-House Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global In-House Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global In-House Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Mobile / On-Site Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Mobile / On-Site Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Mobile / On-Site Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Direct-to-Consumer Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Direct-to-Consumer Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Direct-to-Consumer Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 33. Global Blood / Plasma / Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Blood / Plasma / Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Blood / Plasma / Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Saliva / Buccal Swabs Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Saliva / Buccal Swabs Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Saliva / Buccal Swabs Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Tissue Biopsies Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Tissue Biopsies Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Tissue Biopsies Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Environmental Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Environmental Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Environmental Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 46. Global Rapid / Same-Day Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Rapid / Same-Day Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Rapid / Same-Day Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Short-Term (1-3 Days) Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Short-Term (1-3 Days) Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Short-Term (1-3 Days) Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Standard (4-7 Days) Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Standard (4-7 Days) Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Standard (4-7 Days) Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Global Infectious Disease Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Infectious Disease Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Infectious Disease Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Genetic / Hereditary Disease Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Genetic / Hereditary Disease Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Genetic / Hereditary Disease Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Oncology & Cancer Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Oncology & Cancer Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Oncology & Cancer Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Pharmacogenomics & Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Pharmacogenomics & Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Pharmacogenomics & Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Prenatal & Neonatal Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Prenatal & Neonatal Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Prenatal & Neonatal Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Food & Environmental Safety Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Food & Environmental Safety Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Food & Environmental Safety Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 75. Global Clinical Laboratories & Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Clinical Laboratories & Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Clinical Laboratories & Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Research Institutions & Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Research Institutions & Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Research Institutions & Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Agricultural & Food Safety Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Agricultural & Food Safety Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Agricultural & Food Safety Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Environmental Testing & Regulatory Bodies Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Environmental Testing & Regulatory Bodies Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Environmental Testing & Regulatory Bodies Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 98. North America Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 100. North America Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 101. North America Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 102. North America Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 103. North America Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. North America Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 105. Latin America Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 107. Latin America Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 108. Latin America Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 109. Latin America Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 110. Latin America Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Latin America Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 112. Europe Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Europe Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 114. Europe Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 115. Europe Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 116. Europe Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 117. Europe Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Europe Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 119. Middle East Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Middle East Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 121. Middle East Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 122. Middle East Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 123. Middle East Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 124. Middle East Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Middle East Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 126. Africa Molecular Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Africa Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 128. Africa Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 129. Africa Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 130. Africa Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 131. Africa Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Africa Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 133. Global Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. ASEAN Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. ASEAN Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 136. ASEAN Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 137. ASEAN Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 139. ASEAN Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. ASEAN Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 141. GCC Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. GCC Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 143. GCC Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 144. GCC Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 145. GCC Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 146. GCC Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. GCC Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 148. European Union Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. European Union Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 150. European Union Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 151. European Union Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. European Union Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 153. European Union Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. European Union Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 155. BRICS Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. BRICS Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 157. BRICS Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 158. BRICS Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 159. BRICS Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 160. BRICS Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. BRICS Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 162. G7 Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. G7 Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 164. G7 Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 165. G7 Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 166. G7 Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 167. G7 Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. G7 Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 169. NATO Molecular Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. NATO Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 171. NATO Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 172. NATO Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 173. NATO Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 174. NATO Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. NATO Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 176. Global Molecular Testing Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. United States Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 178. United States Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 179. United States Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 180. United States Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 181. United States Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 182. United States Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. United States Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 184. Canada Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 185. Canada Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 186. Canada Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 187. Canada Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. Canada Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 189. Canada Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Canada Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 191. Mexico Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 192. Mexico Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 193. Mexico Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 194. Mexico Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 195. Mexico Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 196. Mexico Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Mexico Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 198. Brazil Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 199. Brazil Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 200. Brazil Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 201. Brazil Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 202. Brazil Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 203. Brazil Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Brazil Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 205. United Kingdom Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 206. United Kingdom Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 207. United Kingdom Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 208. United Kingdom Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 209. United Kingdom Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 210. United Kingdom Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. United Kingdom Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 212. Germany Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 213. Germany Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 214. Germany Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 215. Germany Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. Germany Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 217. Germany Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Germany Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 219. France Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 220. France Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 221. France Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 222. France Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 223. France Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 224. France Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. France Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 226. Russia Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 227. Russia Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 228. Russia Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 229. Russia Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 230. Russia Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 231. Russia Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Russia Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 233. Italy Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 234. Italy Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 235. Italy Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 236. Italy Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 237. Italy Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 238. Italy Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Italy Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 240. Spain Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 241. Spain Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 242. Spain Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 243. Spain Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. Spain Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 245. Spain Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Spain Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 247. China Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 248. China Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 249. China Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 250. China Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 251. China Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 252. China Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. China Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 254. India Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 255. India Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 256. India Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 257. India Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 258. India Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 259. India Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. India Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 261. Japan Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 262. Japan Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 263. Japan Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 264. Japan Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. Japan Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 266. Japan Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Japan Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 268. Australia Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 269. Australia Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 270. Australia Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 271. Australia Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 272. Australia Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 273. Australia Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Australia Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 275. South Korea Molecular Testing Service Market Size, 2017-2032 (USD Million)
TABLE 276. South Korea Molecular Testing Service Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 277. South Korea Molecular Testing Service Market Size, by Service Model, 2017-2032 (USD Million)
TABLE 278. South Korea Molecular Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 279. South Korea Molecular Testing Service Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 280. South Korea Molecular Testing Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 281. South Korea Molecular Testing Service Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 282. Global Molecular Testing Service Market Share, by Key Player, 2025
TABLE 283. Global Molecular Testing Service Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Becton, Dickinson and Company
  • BGI Genomics Co Ltd
  • bioMérieux SA
  • Bio‑Rad Laboratories Inc
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • Exact Sciences Corporation
  • F. Hoffmann‑La Roche Ltd
  • Genetic Signatures Pty Ltd
  • Grifols S.A.
  • Hologic Inc
  • Illumina Inc
  • MDxHealth SA
  • Molbio Diagnostics Pvt Ltd
  • Myriad Genetics Inc
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Savyon Diagnostics Ltd
  • Seegene Inc
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc

Related Topics

Related Reports

Molecular Diagnostics Market - Global Forecast 2026-2032 - Product Image

Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032 - Product Image

Colorectal Cancer Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Point of Care Molecular Diagnostics Market - Global Forecast 2026-2032 - Product Image

Point of Care Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Polymerase Chain Reaction Market - Global Forecast 2026-2032 - Product Image

Polymerase Chain Reaction Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Nucleic Acids for Molecular Diagnosis Market - Global Forecast 2026-2032 - Product Image

Nucleic Acids for Molecular Diagnosis Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.